patent for semaglutide China's weight-loss drug makers take on global giants as Novo Nordisk expires Viatris gets USPTO to review

Wegovy is FDA-approved for promoting weight loss in adults with obesity (BMI 30 kg/m or more) and overweight (BMI 27 kg/m or more) with at least one health condition associated with increased body weight such as high blood pressure (hypertension), high cholesterol levels, heart diseases, and type 2 diabetes in patients aged 12 or more, when combined with exercise and dietary modifications

It may have other effects in the body that we dont completely understand yet

The mechanism is multifactorial

Diabetes, Obesity & Metabolism, 19 (4), 524536

A vast library of 1.3 trillion posts, collected over 10 years, informs a language-agnostic AI, covering a broad range of countries and social platforms including the ones such as forums, Reddit, and Facebook that host detailed consumer discussions

B12 vitamins produce melatonin, which controls our sleep and wake cycles